Time Trends in Incidence of Haematological Malignancies and Related Conditions

Cartwright, R. A.; Gilman, E A; Gurney, Karen

doi:10.1046/j.1365-2141.1999.01480.x

Cited by 28 publications

(28 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As these three latter factors have changed substantially during our study period, any trend in both the incidence rate and the prevalence is likely to be affected by this. We observed a steady increase in the incidence of NHL across all age groups in line with previous reports [14,15]. However, the small number of patients in most age groups precluded us from making conclusions regarding trends in incidence rate among older patients with MM, CLL, and AML.…”

Section: Discussionsupporting

confidence: 91%

Trends in hematological cancer in the elderly in Denmark, 1980–2012

et al. 2016

View full text Add to dashboard Cite

Background The number of hematological malignancies is expected to increase as the Danish population ages within the next few decades. Despite this, data on the course of hematological cancers among the oldest patients are sparse with many intervention studies focusing on younger age groups. The aim of this study is to present Danish incidence and mortality rates among older patients with non-Hodgkin lymphomas (NHL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML). Material and methods Nationwide population-based study presenting the incidence, prevalence and mortality rates of NHL, MM, and AML with a focus on the elderly population in Denmark during the last few decades. Data were drawn from the NORDCAN database. Results Incidence rates of NHL, MM, CLL and AML were 10-50 times higher among the population aged 70 years or more than among the younger population. An increasing incidence with stable or decreased mortality rates was seen mainly among elderly patients with NHL during the last few decades, leading to increased survival and a greater prevalence of patients with NHL. Increased relative survival and prevalence could also be seen among elderly patients with MM and CLL, while the trends of the incidence rates were inconclusive for these diseases. Survival among patients with AML improved most notably in those aged below 70 years leading to an increased prevalence of AML patients predominantly in this age group. Conclusion Improvements in diagnostics and treatment have led to increased survival and therefore prevalence of elderly patients with NHL, MM, CLL and AML during the past decades.

show abstract

Section: Discussionsupporting

confidence: 91%

Trends in hematological cancer in the elderly in Denmark, 1980–2012

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Worldwide prevalence of multiple myeloma is widely variation when compared with other hematological malignancies (Vineis et al, 1996). The age adjusted prevalence of multiple myeloma per 10000 population was found 0.5, 0.9-3.3 and 8.2 in Hawaiian Japanese men, most European Countries and San Francisco Bay Area black men respectively (Riedel & Pottern, 1992;Cartwright et al, 1999;Phekoo et al, 2004). Prevalence of multiple myeloma is lower in Asian country compared with western country.…”

Section: Introductionmentioning

confidence: 96%

Liver Involvement in Multiple Myeloma: A Hospital Based Retrospective Study

Poudel¹,

Mittal²,

Shrestha³

et al. 2012

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

“…1 The etiology of lymphoid neoplasms remains largely unknown, although risk factors include certain infections as well as treatments and diseases that cause severe immunosuppression. [2][3][4][5][6][7][8][9] Beginning prior to 1950, an epidemic of NHL but not other hematopoietic neoplasms has been well documented in many populations, 10,11 with an estimated 50% increase in United States age-adjusted incidence from 1970 to 1990 [11][12][13][14] (Figure 1). Changes in diagnostic practice over time and the emergence of the human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) pandemic in the early 1980s contributed to the rise in NHL but are not sufficient to explain entirely these dramatic increases.…”

Section: Introductionmentioning

confidence: 99%

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

Morton

Wang

Devesa

et al. 2006

Blood

1,504

1,117

View full text Add to dashboard Cite

Age-specific and age-adjusted rates were compared by sex and race (white, black, Asian). Age-adjusted trends in incidence were estimated by sex and race using weighted least squares log-linear regression. Diverse incidence patterns and trends were observed by lymphoid neoplasm subtype and population. In the elderly (75 years or older), rates of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma increased 1.4% and 1.8% per year, respectively, whereas rates of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) declined 2.1% per year. Although whites bear the highest incidence burden for most lymphoid neoplasm subtypes, most notably for hairy cell leukemia and follicular lymphoma, black predominance was observed for plasma cell and T-cell neoplasms. Asians have considerably lower rates than whites and blacks for CLL/SLL and Hodgkin lymphoma. We conclude that the striking differences in incidence patterns by histologic subtype strongly suggest that there is etiologic heterogeneity among lymphoid neoplasms and support the pursuit of epidemiologic analysis by subtype. (Blood. 2006;107:265-276)

show abstract

Time Trends in Incidence of Haematological Malignancies and Related Conditions

Cited by 28 publications

References 44 publications

Trends in hematological cancer in the elderly in Denmark, 1980–2012

Trends in hematological cancer in the elderly in Denmark, 1980–2012

Liver Involvement in Multiple Myeloma: A Hospital Based Retrospective Study

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

Contact Info

Product

Resources

About